Effect of propaquizafop and its free-acid derivative on lauric acid hydroxylation and peroxisomal β-oxidation in primary cultured rat, mouse, guinea pig and marmoset hepatocytes-Reference-Cited by-同舟云学术

Effect of propaquizafop and its free-acid derivative on lauric acid hydroxylation and peroxisomal β-oxidation in primary cultured rat, mouse, guinea pig and marmoset hepatocytes

Published:1993-07 Issue:4 Volume:7 Page:427-431
ISSN:0887-2333
Container-title:Toxicology in Vitro
language:en
Short-container-title:Toxicology in Vitro

Author:

Bouis P.,Bieri F.,Lang B.,Thomas H.,Waechter F.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference21 articles.

1. Clofibrate-inducible rat hepatic P450s IVA1 and IVA3 catalyze the omega- and (omega-1)-hydroxylation of fatty acids and the omega-hydroxylation of prostaglandins E1 and F2α;Aoyama;Journal of Lipid Research,1990

2. High pressure liquid chromatography methods for separation of omega- and (omega-1)-hydroxy fatty acids: their applications to microsomal fatty acid omega-oxidation;Aoyama;Analytical Biochemistry,1988

3. Induction of the cytochrome P450 I and IV families and peroxisomal proliferation in the liver of rats treated with benoxaprofen. Possible implications in its hepatotoxicity;Ayrton;Biochemical Pharmacology,1991

4. Hepatic Peroxisome Proliferation;Bentley;ECETOC Monograph,1992

5. Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture;Bichet;Toxicology and Applied Pharmacology,1990

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marmoset cytochrome P450 4A11, a novel arachidonic acid and lauric acid ω-hydroxylase expressed in liver and kidney tissues;Xenobiotica;2016-07-20

2. Species differences in peroxisome proliferation; mechanisms and relevance;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;2000-03

3. A Cancer Risk Assessment of Di(2-ethylhexyl)phthalate: Application of the New U.S. EPA Risk Assessment Guidelines;Regulatory Toxicology and Pharmacology;1999-06